AFG
RLAY icon

American Financial Group’s Relay Therapeutics RLAY Stock Holding History

American Financial Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,484
Closed -$224K – 92
2022
Q1 		$224K Hold
7,484
– – 0.07% 83
2021
Q4 		$230K Hold
7,484
– – 0.06% 85
2021
Q3 		$236K Hold
7,484
– – 0.06% 84
2021
Q2 		$274K Buy
+7,484
New +$247K 0.07% 83

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

American Financial Group's RLAY Position: Q2 2022 in Review

American Financial Group sold out of Relay Therapeutics (RLAY) in Q2 2022, closing a stake of 7,484 shares — an estimated $224K sold.

American Financial Group first reported a position in RLAY in Q2 2021 and held it in 4 quarters. The position peaked at $274K in Q2 2021. 148 funds tracked by Wall St. Rank hold RLAY as of Q2 2022.

  • American Financial Group reported no remaining Relay Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American Financial Group sold 7,484 Relay Therapeutics shares in Q2 2022, an estimated $224K.
  • American Financial Group first reported a position in Relay Therapeutics in Q2 2021 and held it in 4 quarters.
  • American Financial Group's Relay Therapeutics position peaked at $274K in Q2 2021.
  • 148 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2022.

Based on American Financial Group's 13F filing for Q2 2022, filed 5 Aug 2022.